Results 81 to 90 of about 23,766 (215)
Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014. [PDF]
, 2015 On July 9, 2014, Aeras and the Max Planck Institute for Infection Biology convened a workshop entitled "Whole Mycobacteria Cell Vaccines for Tuberculosis" at the Max Planck Institute for Infection Biology on the grounds of the Charité Hospital ...
(including White, RG +2 more
core +1 more source
Helminths as architects of trained tolerance: implications for human health
Clinical &Translational Immunology, Volume 15, Issue 3, 2026.Abstract Helminths infect nearly 2 billion people worldwide and are a major cause of chronic morbidity in low‐resource regions. Unlike bacterial and viral pathogens that elicit protective memory, helminths actively remodel host immunity to enable their years‐long persistence and reinfection.
Quinn Moroz +2 more
wiley +1 more source
Ecology and Evolution, Volume 16, Issue 3, March 2026.Anthropogenic change has facilitated the spread of the amphibian chytrid fungus Batrachochytrium dendrobatidis (Bd) in Brazil's Atlantic Forest, where two Bd lineages (Bd‐GPL and Bd‐Brazil) co‐occur. We successfully genotyped 252 Bd‐positive samples from a diverse amphibian assemblage spanning aquatic and terrestrial habitats and found that Bd lineage ...
Shannon Buttimer +7 more
wiley +1 more source
Health Science Reports, Volume 9, Issue 3, March 2026.ABSTRACT Background and Aims Africa has significant challenges in meeting its vaccination needs, including inadequate manufacturing capacity, infrastructure deficiencies, a scarcity of experienced personnel, regulatory hurdles, restricted access to technology and intellectual property.
Courage Chandipwisa +3 more
wiley +1 more source
Expert Review of Vaccines, 2018 Introduction: Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome, tuberculosis, and malaria are responsible for most human deaths produced by infectious diseases worldwide.
Athina Kilpeläinen +4 more
doaj +1 more source
Multiscale Nanocellulosic Biomaterials in Therapeutics and Food Sciences
Small Structures, Volume 7, Issue 3, March 2026.Multiscale nanocellulosic biomaterials offer exceptional physicochemical, mechanical, and biological properties; enabling transformative advances in therapeutics and food sciences. This review summarizes their structure–property relationships, key applications in drug delivery, tissue engineering, and food technology. Additionally, it outlines emerging
Hemant Singh +9 more
wiley +1 more source
BCG-induced trained immunity: history, mechanisms and potential applications
Journal of Translational Medicine, 2023 The Bacillus Calmette-Guérin (BCG) vaccine was discovered a century ago and has since been clinically applicable. BCG can not only be used for the prevention of tuberculosis, but also has a non-specific protective effect on the human body called trained ...
Jingjing Chen +9 more
doaj +1 more source
Recombinant BCG as a vaccine vehicle to protect against tuberculosis [PDF]
Bioengineered Bugs, 2010 Mycobacterium bovis Bacille Calmette Guérin (BCG) was first administered to humans in 1921 and has subsequently been delivered to an estimated 3 billion individuals, with a low incidence of serious complications. The vaccine is immunogenic and is stable and cheap to produce.
openaire +2 more sources
Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy [PDF]
, 2016 The development of a tuberculosis (TB) vaccine that induces sterilizing immunity to Mycobacterium tuberculosis infection has been elusive. Absence of sterilizing immunity induced by TB vaccines may be due to delayed activation of mucosal dendritic cells (
Ahmed, Mushtaq +11 more
core +2 more sources
Vaccination and transfusion safety at the time of expanding use of live attenuated vaccines
Vox Sanguinis, EarlyView.
Pierre Tiberghien +4 more
wiley +1 more source